Metraipolis › archive › dc_bf1a02a218e7

Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42761776
DOI
10.3389/fonc.2026.1940181
License (as archived)
solo-consultazione
Archived
2026-10-16T03:25:29.903Z
SHA-256 of the archived text
f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76
Stable URL of this page
https://metraipolis.com/documento/dc_bf1a02a218e7

How to cite

Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776 — Europe PMC (en), https://europepmc.org/article/MED/42761776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf1a02a218e7 (Metraipolis archive dc_bf1a02a218e7, sha256 f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76)
BibTeX
@misc{dcbf1a02a218e7,
  title = {Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42761776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf1a02a218e7; sha256 f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42761776. Agents can read the archived copy with the MCP tool read_document.